Jeffrey Bacha

Jeffrey Bacha

Chairman bei RAKOVINA THERAPEUTICS INC.

Vermögen: 404 898 $ am 31.03.2024

56 Jahre
Health Technology
Finance
Consumer Services

Profil

Jeffrey A.
Bacha
was the founder of Kintara Therapeutics, Inc. (founded in 2009) and Del Mar Pharmaceuticals (BC) Ltd.
(founded in 2010), where he holds the titles of Director and President, Chief Executive Officer & Director respectively.
He currently holds the position of Chief Executive Officer & Director at Edison Oncology Holding Corp., CEO, Chief Financial Officer & Director at NewGen Therapeutics, Inc., Executive Chairman at Rakovina Therapeutics, Inc., Director at Leukemia & Lymphoma Society Greater San Francisco Bay Area, Independent Director at AD4 Capital Corp., and Member-Research Roundtable at National Brain Tumor Society, Inc. Mr. Bacha's former positions include President & Chief Executive Officer at Inimex Pharmaceuticals, Inc., Chairman at Covenant House Vancouver, Independent Director at Sernova Corp., Director at CalEthos, Inc., Director & Senior Manager at KPMG Health Ventures, Founding Director at Urigen Holdings, Inc., Vice President-Corporate Development at EACOM Timber Corp., Chief Operating Officer & Executive Vice President at Clerac LLC, Chief Financial Officer & VP-Corporate Development at XBiotech USA, Inc., and Chief Operating Officer & EVP-Corporate Affairs at Clera Inc. Mr. Bacha obtained his undergraduate degree from the University of California San Diego in 1991 and his MBA from Goizueta Business School-Emory in 1995.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
25.04.2023 614 980 ( 0,20% ) 252 757 $ 31.03.2024
19.04.2024 1 822 857 ( 2,80% ) 134 891 $ 31.03.2024
31.10.2022 250 000 ( 1,61% ) 17 250 $ 31.03.2024

Aktive Positionen von Jeffrey Bacha

UnternehmenPositionBeginn
RAKOVINA THERAPEUTICS INC. Chairman 01.12.2020
AD4 CAPITAL CORP. Director/Board Member 23.06.2021
Leukemia & Lymphoma Society Greater San Francisco Bay Area Director/Board Member -
Corporate Officer/Principal -
Chief Executive Officer -
Chief Executive Officer -
Founder 18.10.2010
Alle aktiven Positionen von Jeffrey Bacha

Ehemalige bekannte Positionen von Jeffrey Bacha

UnternehmenPositionEnde
SERNOVA CORP. Director/Board Member 01.01.2022
KINTARA THERAPEUTICS, INC. Chief Executive Officer 07.11.2017
░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Sehen Sie sich die Erfahrung von Jeffrey Bacha im Detail an

Ausbildung von Jeffrey Bacha

University of California San Diego Undergraduate Degree
Goizueta Business School-Emory Masters Business Admin

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Jeffrey Bacha im Detail an

Beziehungen

100 +

Beziehungen ersten Grades

20

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen5
SERNOVA CORP.

Health Technology

KINTARA THERAPEUTICS, INC.

Health Technology

CALETHOS, INC.

Finance

RAKOVINA THERAPEUTICS INC.

Finance

AD4 CAPITAL CORP.

Finance

Private Unternehmen13

Non-Energy Minerals

Health Technology

Finance

Leukemia & Lymphoma Society Greater San Francisco Bay Area

KPMG Health Ventures

Health Services

Health Technology

Commercial Services

Health Technology

Urigen Holdings, Inc.

Commercial Services

Finance

Health Technology

Sehen Sie sich die Unternehmensverbindungen an
  1. Börse
  2. Insiders
  3. Jeffrey Bacha